Search

everythinglearnresearchcommunity

for

Search:↓

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Nails can reveal important health information about skin and body conditions.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

COVID-19 vaccination may trigger lupus in some people.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

A woman with multiple autoimmune diseases showed improvement in hair loss but not in skin discoloration after treatment.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

General practitioners in Qassim have satisfactory knowledge of alopecia areata but need more education to address gaps and misconceptions.

Early intervention and patient education are crucial for managing alopecia areata.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Microneedling combined with triamcinolone can safely stimulate faster hair regrowth in people with Alopecia Areata.

People with alopecia have a higher risk of thyroid cancer.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.